Exact Sciences Corporation (EXAS) Financials

EXAS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 6.5 billion 3.3 billion
2023-09-30 6.4 billion 3.3 billion
2023-06-30 6.4 billion 3.3 billion
2023-03-31 6.3 billion 3.2 billion

EXAS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 34.6 million 58.6 million
2023-09-30 -826000 61.9 million
2023-06-30 65.7 million 18600
2023-03-31 -67.6 million 49.1 million

EXAS Net Income

No data available :(

EXAS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 777.6 million - 190.4 million
2023-09-30 734.4 million - 168.4 million
2023-06-30 775.7 million - 168.5 million
2023-03-31 698.6 million - 174.7 million

EXAS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 181.1 million
2023-09-30 184.1 million
2023-06-30 180.2 million
2023-03-31 178.6 million

EXAS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 34.9 million 114.9 million 353.4 million 57.6 million
2023-09-30 25.2 million 111.4 million 217.4 million 173.2 million
2023-06-30 34.7 million 104.1 million 238.0 million 176.5 million
2023-03-31 29.4 million 95.4 million 217.3 million 187.0 million

EXAS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 646.9 million 171.8 million
2023-09-30 628.3 million 168.5 million
2023-06-30 622.1 million 157.0 million
2023-03-31 602.5 million 156.9 million

EXAS

Price: $59.76

52 week price:
56.05
100.77

Earnings Per Share: -1.13 USD

P/E Ratio: -39.52

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 953316

Ebitda: -23.0 million

Market Capitalization: 11.4 billion

Links: